These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 10903238
1. Withdrawal of chronic systemic corticosteroids in patients with COPD: a randomized trial. Rice KL, Rubins JB, Lebahn F, Parenti CM, Duane PG, Kuskowski M, Joseph AM, Niewoehner DE. Am J Respir Crit Care Med; 2000 Jul; 162(1):174-8. PubMed ID: 10903238 [Abstract] [Full Text] [Related]
2. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Leuppi JD, Schuetz P, Bingisser R, Bodmer M, Briel M, Drescher T, Duerring U, Henzen C, Leibbrandt Y, Maier S, Miedinger D, Müller B, Scherr A, Schindler C, Stoeckli R, Viatte S, von Garnier C, Tamm M, Rutishauser J. JAMA; 2013 Jun 05; 309(21):2223-31. PubMed ID: 23695200 [Abstract] [Full Text] [Related]
3. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Am J Respir Crit Care Med; 1996 Aug 05; 154(2 Pt 1):407-12. PubMed ID: 8756814 [Abstract] [Full Text] [Related]
4. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA. N Engl J Med; 1999 Jun 24; 340(25):1941-7. PubMed ID: 10379017 [Abstract] [Full Text] [Related]
10. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Woodle ES, First MR, Pirsch J, Shihab F, Gaber AO, Van Veldhuisen P, Astellas Corticosteroid Withdrawal Study Group. Ann Surg; 2008 Oct 24; 248(4):564-77. PubMed ID: 18936569 [Abstract] [Full Text] [Related]
11. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial. Zheng JP, Wen FQ, Bai CX, Wan HY, Kang J, Chen P, Yao WZ, Ma LJ, Li X, Raiteri L, Sardina M, Gao Y, Wang BS, Zhong NS, PANTHEON study group. Lancet Respir Med; 2014 Mar 24; 2(3):187-94. PubMed ID: 24621680 [Abstract] [Full Text] [Related]